Impact Omics

Tongersesteenweg 15

3840 Borgloon


Impact Omics

Foundation date



#Biotechnology / R&D Services


Therapeutic areas

Impact Omics is establishing a lab service based on a proprietary genomics workflow to aid general practitioners in Primary Care with their treatment selection for various (infectious) diseases.

Upcoming events

Latest news

  • Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

    2 hours ago

  • Triple discovery unveils insights into type 2 diabetes

    Thursday September 28th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023